InsiderTrades

Form 4 for ISRG Intuitive Surgical

Accepted 2023-10-26 00:00:00 ET · period of report 2023-10-24 · accession 0001035267-23-000200 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2023-10-26 2023-10-26 ISRG GUTHART GARY S CEO, Dir M - OptEx $49.34 +33.8K 50.9K +196% +$1.67M
DMI 2023-10-26 2023-10-24 ISRG GUTHART GARY S CEO, Dir S - Sale+OE $271.93 -4,960 29.8K -14% -$1.35M
D 2023-10-26 2023-10-26 ISRG GUTHART GARY S CEO, Dir S - Sale+OE $260.11 -27.4K 23.6K -54% -$7.12M
D 2023-10-26 2023-10-26 ISRG GUTHART GARY S CEO, Dir M - OptEx $0.00 -33.8K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-10-26 M A 33,750 $49.34 50,936 D by Trust FBO Daughte — —
2 Common Common Stock 2023-10-24 S D 2,480 $271.93 29,840 I — —
3 Common Common Stock 2023-10-24 S D 2,480 $271.93 29,840 I — —
4 Common Common Stock 2023-10-26 S D 27,385 $260.11 23,551 D by Trust FBO Son — — (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $256.16 to $264.24 as follows: 2,409 shares sold at $256.16 to $257.16; 3,572 shares sold at $257.17 to $258.02; 3,090 shares sold at $258.24 to $258.97; 9,133 shares sold at $259.72 to $260.69; 4,304 shares sold at $260.75 to $261.53; 2,750 shares sold at $261.93 to $262.55 and 2,127 shares sold at $264.24. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
5 Derivative Non-Qualified Stock Option (right to buy) 2023-10-26 M D 33,750 $0.00 0 D $49.34 · — to 2024-02-18 33,750 Common Stock (F3) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.